AI Lifesciences

• AI Just Added $942 Million to US Healthcare Costs

  "All the insurers are using AI to scan our charts to look for claims to deny."

• Oracle Health Announced Five AI Tools for Revenue Cycle Management

  "AI gives us an opportunity to prevent revenue cycle problems before they lead to denials and delayed payments."

• University Hospital at Downstate Deploys Altera’s AI Scribe Across Clinical Care

  Sunrise Thread AI has been used in more than 900 patient encounters since May, with 50 providers across four clinical departments.

• AbbVie Partners With Iambic to Accelerate AI-Driven Drug Discovery

  AbbVie will use Iambic's AI platform and Enchant v3 to accelerate small-molecule drug discovery across immunology, neuroscience and oncology.

• Sentara Health Pilots GW RhythmX AI Platform for Primary Care

  Sentara Health is testing GW RhythmX’s AI platform with 30 primary care clinicians to evaluate clinical recommendations, adoption and workflow fit.

• OpenEvidence and Penn Medicine Partner to Bring AI Clinical Decision Support to Botswana

  Penn Medicine and OpenEvidence will deploy AI-powered clinical decision support across Penn's health system and extend the program to Botswana.

• Novo Nordisk Turns to Anthropic to Accelerate AI-Driven Drug Development

  Novo Nordisk will test Anthropic’s Claude Science in R&D workflows as it expands AI use across drug discovery and software development.

• GE HealthCare Launches AI Tool to Forecast Hospital Capacity Bottlenecks

  GE HealthCare's new CareIntellect for Operations uses AI to forecast hospital capacity constraints up to 72 hours in advance.

• Cleveland Clinic Partners With Luminai to Transform Health System Operations

  Cleveland Clinic is partnering with Luminai to automate complex administrative workflows, starting with the processing of faxed patient referrals.

• Battelle Study Finds AI Skills Alone Are Not Enough for Workforce Readiness

  Battelle’s new workforce study finds employers increasingly value critical thinking, communication and adaptability alongside AI skills.

• UF Health Partners with R1 to Deploy AI-Powered Revenue Cycle Platform

  UF Health is working with R1 to deploy an AI-native revenue cycle model using Phare OS, combining agent-driven workflows with human oversight.

• Rentosertib Shows Potential to Lower Biological Age in Small AI Drug Study

  An AI-developed lung disease drug lowered biological age markers across six aging clocks, but researchers cautioned that the findings remain preliminary.

• Qualderm Partners With Parakeet Health to Expand AI-Powered Patient Access

  The national dermatology network will use Parakeet Health’s agentic AI to reconnect patients and fill unused appointment capacity across nearly 160 practices.

• Adventist Health Launches Epic System With Expanded AI Integration

  The health system connected 27 hospitals and more than 440 clinics through one EHR while deploying Epic’s AI tools across its network.

• OSF Expands AI Stroke Assessment to Rural Hospitals Across Its Network

  OSF HealthCare is expanding RapidAI stroke imaging tools to rural hospitals, giving neurologists faster access to brain scans and blood-flow data.

• Philips Names Shez Partovi Chief AI Officer, Laura Matz Technology Chief

  Philips appointed Shez Partovi as its first Chief AI Officer and Laura Matz as Chief Innovation and Technology Officer.

• Abcam Expands Genedata Partnership To Accelerate AI-Driven Antibody Development

  Abcam has deployed Genedata Biologics across key R&D sites to unify antibody data and support faster AI-enabled development.

• TriHealth Expands AI Use From Hospital Rooms To Medical Imaging

  TriHealth is using AI for virtual nursing and medical imaging as it seeks to improve patient monitoring, clinical workflows and staff capacity.

• Caris AI Study Links Treatment Selection to Longer Survival in Pancreatic Cancer

  A Caris study found AI-guided treatment selection was associated with longer survival in pancreatic cancer patients using molecular data.

• Intermountain Medical Center Deploys AI-Powered MRI To Speed Up Scans

  Intermountain Medical Center has begun using GE HealthCare's AI-powered MRI to produce clearer images and shorten scan times.

• Philips Gets Up To $33.7 Million ARPA-H Award For Robotic Stroke Care

  Philips received up to $33.7 million from ARPA-H to develop AI-enabled robotic systems for remote and increasingly automated stroke procedures.

• Syneos Health Names Madhuri Raya Global Head of AI and Engineering

  Syneos Health appointed Madhuri Raya as Global Head, AI and Engineering as it expands AI across clinical development and commercialization.

• Elsevier Launches Nora AI For Healthcare Education

  Elsevier launched Nora AI, an AI learning assistant embedded in Elsevier eBooks to support healthcare students and educators with sourced answers.

• HearingLife Launches Oticon Reveal With Dual AI Hearing Technology

  HearingLife has begun offering Oticon Reveal, a hearing aid that uses two AI systems to process speech and surrounding sounds in real time.

• AI Helped Build a Personalized Cancer Vaccine. It Just Passed Phase 3

  A personalized mRNA vaccine, designed with help from an algorithm, met its main goals in a Phase 3 melanoma trial run by Merck and Moderna.

• Gallion Health Names Yale New Haven Health Development Partner and Investor

  Gallion Health will pilot its bill-only supply chain platform across Yale New Haven Health while co-developing new features and AI capabilities.

• Prior Authorization is Healthcare's Hardest AI Problem, says Sagility's Anand Biradar

  Healthcare is choosing caution over speed on AI-led prior authorization, and for good reason.

• Summa Health Adds AI Tools For Scans, Referrals And Operations

  Summa Health is deploying AI across imaging, referrals, supply ordering and patient workflows as part of HATCo’s health system transformation plan.

• Mayo Clinic Names New CIO As It Expands Its AI Strategy

  Mayo Clinic appointed Arun Kumar Bhaskara-Baba as CIO as it expands AI infrastructure, clinical research and a frontier model with Microsoft.

• Syneos Health Partnered With Causaly, Databricks and Microsoft to Put AI Inside Clinical Trials

  "Our priority is AI that works inside the complexity of clinical trials."

• Intermountain Health Deploys AI Imaging System for Breast Cancer Surgery

  Intermountain Health has commercially deployed Perimeter’s FDA-approved Claire system to help surgeons assess breast cancer margins during surgery.

• OSF HealthCare Expands RapidAI Across 18 Hospitals to Speed Stroke Care

  OSF HealthCare is expanding RapidAI across 18 hospitals in Illinois and Michigan to support faster stroke imaging and care coordination.

• Twelve US Health Systems Join Aidoc To Form Diagnostic AI Consortium

  Twelve US health systems, including Advocate Health, Cedars-Sinai and Northwell Health, have joined Aidoc to develop diagnostic AI, with results expected in 2027.

• LCMC Health Partners With Qualified Health to Expand Enterprise AI Across Care

  LCMC Health is partnering with Qualified Health to deploy generative AI across clinical, operational, and revenue-cycle workflows.

• Hims & Hers Is Building AI into Its Consumer Healthcare Business

  Hims & Hers is using AI to connect customers, clinicians, labs and support teams as it expands beyond its original telehealth model.

• Doximity Ramps AI Spending as Hospitals Shift Toward Enterprise Adoption

  Doximity raised its fiscal 2027 outlook as 165 health systems adopted its AI tools, while higher AI spending weighs on near-term margins.

• Evolent Bets on AI-Led Operations as It Raises 2026 Revenue Outlook

  Evolent raised its 2026 revenue guidance after reporting 47% revenue growth in Q2, with executives pointing to an AI-led operating model and new oncology partnerships.

• Astrana Health Credits AI-Native Platform as Q2 Revenue Climbs 49%

  Astrana Health raised its 2026 EBITDA outlook after reporting strong second-quarter growth driven by its AI-native healthcare platform.

• AI Stayed in the Background During Lilly and Novartis' Earnings Calls

  Eli Lilly and Novartis spent little time discussing quarterly earnings, focusing instead on R&D, acquisitions, and the next generation of medicines.

• GenScript Partners With Tamarind Bio to Speed AI Drug Discovery Validation

  GenScript and Tamarind Bio have partnered to connect AI-powered molecular design with wet-lab validation, aiming to help researchers evaluate drug candidates faster.